Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally.
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has Core Laboratories's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CLB's share price has been volatile over the past 3 months.
7 Day Return
US Energy Services
1 Year Return
US Energy Services
Return vs Industry: CLB underperformed the US Energy Services industry which returned -49.2% over the past year.
Return vs Market: CLB underperformed the US Market which returned 9.1% over the past year.
Price Volatility Vs. Market
How volatile is Core Laboratories's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall StDoes Core Laboratories N.V.'s (NYSE:CLB) CEO Salary Compare Well With Others?
1 month ago | Simply Wall StWhat Is Core Laboratories's (NYSE:CLB) P/E Ratio After Its Share Price Rocketed?
1 month ago | Simply Wall StCore Laboratories N.V. (NYSE:CLB) Earns Among The Best Returns In Its Industry
Is Core Laboratories undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: CLB ($20.23) is trading above our estimate of fair value ($14.26)
Significantly Below Fair Value: CLB is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: CLB is unprofitable, so we can't compare its PE Ratio to the Energy Services industry average.
PE vs Market: CLB is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate CLB's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: CLB is overvalued based on its PB Ratio (13.7x) compared to the US Energy Services industry average (0.5x).
How is Core Laboratories forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CLB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: CLB is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CLB's is expected to become profitable in the next 3 years.
Revenue vs Market: CLB's revenue is expected to decline over the next 3 years (-1.7% per year).
High Growth Revenue: CLB's revenue is forecast to decline over the next 3 years (-1.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CLB's Return on Equity is forecast to be high in 3 years time (20.2%)
How has Core Laboratories performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CLB is currently unprofitable.
Growing Profit Margin: CLB is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: CLB is unprofitable, and losses have increased over the past 5 years at a rate of -22.5% per year.
Accelerating Growth: Unable to compare CLB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLB is unprofitable, making it difficult to compare its past year earnings growth to the Energy Services industry (-54.7%).
Return on Equity
High ROE: CLB has a negative Return on Equity (-77.56%), as it is currently unprofitable.
How is Core Laboratories's financial position?
Financial Position Analysis
Short Term Liabilities: CLB's short term assets ($219.7M) exceed its short term liabilities ($108.4M).
Long Term Liabilities: CLB's short term assets ($219.7M) do not cover its long term liabilities ($468.1M).
Debt to Equity History and Analysis
Debt Level: CLB's debt to equity ratio (436.3%) is considered high.
Reducing Debt: CLB's debt to equity ratio has reduced from 1123.1% to 436.3% over the past 5 years.
Debt Coverage: CLB's debt is well covered by operating cash flow (28.3%).
Interest Coverage: CLB is unprofitable, therefore interest payments are not well covered by earnings.
What is Core Laboratories's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CLB's dividend (0.2%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.69%).
High Dividend: CLB's dividend (0.2%) is low compared to the top 25% of dividend payers in the US market (4.48%).
Stability and Growth of Payments
Stable Dividend: CLB is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: CLB is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: CLB is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of CLB's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Larry Bruno (59yo)
Mr. Lawrence V. Bruno, also known as Larry, serves as Chairman of Supervisory Board and Chief Exertive Officer at Core Laboratories N.V. since May 20, 2020. He has been Supervisory Director of Core Laborat ...
CEO Compensation Analysis
Compensation vs Market: Larry's total compensation ($USD2.97M) is about average for companies of similar size in the US market ($USD3.20M).
Compensation vs Earnings: Larry's compensation has increased whilst the company is unprofitable.
|Chairman of the Board||no data||US$2.97m||0.024% $219.7k|
|Senior VP & CFO||2yrs||US$1.09m||0.034% $306.9k|
|Executive Officer||no data||US$11.18m||1.56% $14.1m|
|Chief Accounting Officer||1.92yrs||no data||0.0014% $13.0k|
|Senior Vice President of Corporate Development & Investor Relations||3.75yrs||no data||no data|
|Senior VP||12.17yrs||no data||0.11% $954.3k|
|Managing Director||no data||US$174.34k||no data|
|Senior VP of Production Enhancement & Business Development||0.33yr||no data||no data|
Experienced Management: CLB's management team is considered experienced (2 years average tenure).
|Chairman of the Board||no data||US$2.97m||0.024% $219.7k|
|Independent Supervisory Director||no data||no data||0.0045% $40.5k|
|Independent Supervisory Director||4.33yrs||US$258.14k||0.0077% $69.2k|
|Lead Independent Director||no data||US$258.21k||0.014% $128.8k|
|Independent Supervisory Director||8yrs||US$236.34k||0.012% $111.2k|
|Independent Supervisory Director||1yr||US$119.14k||0.034% $306.8k|
|Independent Supervisory Director||no data||no data||no data|
Experienced Board: CLB's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: CLB insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Core Laboratories N.V.'s company bio, employee growth, exchange listings and data sources
- Name: Core Laboratories N.V.
- Ticker: CLB
- Exchange: NYSE
- Founded: 1936
- Industry: Oil and Gas Equipment and Services
- Sector: Energy
- Market Cap: US$899.359m
- Shares outstanding: 44.46m
- Website: https://www.corelab.com
Number of Employees
- Core Laboratories N.V.
- Tower A
- Level 9
- 1077 XX
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CLB||NYSE (New York Stock Exchange)||Yes||Common Shares||US||USD||Sep 1995|
|CEI||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Sep 1995|
|CLB||ENXTAM (Euronext Amsterdam)||Yes||Common Shares||NL||EUR||Sep 1995|
|0Q82||LSE (London Stock Exchange)||Yes||Common Shares||GB||EUR||Sep 1995|
|CLBA||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||EUR||Sep 1995|
|CLB N||BMV (Bolsa Mexicana de Valores)||Yes||Common Shares||MX||MXN||Sep 1995|
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment comprises services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/30 03:21|
|End of Day Share Price||2020/05/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.